Stock Market Alert: VRTX surged on Friday, trading up over 6 points to close at $40.66 after the company announced that its treatment for Hepatitis C reduced the virus to undetectable levels in a majority of patients in early-stage clinical trials. Volume surged on the news, with over 14 million shares of the stock changing hands, compared to a normal daily average of over 1.3 million shares traded. The stock is now within 4 points of its 52 week high of $44.71, and currently has a market cap of $4.55 billion dollars.
Sorry, the comment form is closed at this time.